Search research articles
Contact Us
Filters
Showing results (71-80 of 101) with videos related to
Page
of 11
Sort By:
International Journal of Clinical Oncology
|
September 18, 2014
Initial experience of combined use of photodynamic diagnosis and narrow band imaging for detection of flat urothelial lesion
Yoshio Naya, Masakastu Oishi, Yasunori Yamada, et al.
World Journal of Urology
|
July 31, 2020
Moving away from systematic biopsies: image-guided prostate biopsy (in-bore biopsy, cognitive fusion biopsy, MRUS fusion biopsy) -literature review
Yasuhiro Yamada, Osamu Ukimura, Masatomo Kaneko, et al.
Biochemical and Biophysical Research Communications
|
February 26, 2017
CNPY2 promoted the proliferation of renal cell carcinoma cells and increased the expression of TP53
Hidefumi Taniguchi, Saya Ito, Takashi Ueda, et al.
Medicine
|
March 20, 2015
Importance of continuous sequential chemotherapy and multimodal treatment for advanced testicular cancer: a high-volume Japanese center experience
Terukazu Nakamura, Takashi Ueda, Masakatsu Oishi, et al.
Japanese Journal of Clinical Oncology
|
July 3, 2026
Screening for prognostic indicators in patients with metastatic castration-resistant prostate cancer after androgen receptor signaling inhibitor treatment for metastatic castration-sensitive prostate cancer
Keita Hayakawa, Takashi Ueda, Yusuke Gabata, et al.
International Immunopharmacology
|
September 12, 2022
Corrigendum to "A real-world study on the safety of the extended dosing schedule for nivolumab and pembrolizumab in patients with solid tumors" [Int. Immunopharmacol. 108 (2022) 108775]
Kenji Morimoto, Tadaaki Yamada, Yoshie Morimoto, et al.
Current Oncology (Toronto, Ont.)
|
November 26, 2025
A Multicenter Retrospective Study of Avelumab First-Line Maintenance and Subsequent Therapies for Locally Advanced and Metastatic Urothelial Carcinoma: Subgroup Analysis of First-Line Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin, and Gemcitabine Plus Cisplatin in the Japan AVElumab MAintenance and Continuous Treatment Study (JAVEMACS)
Masaomi Ikeda, Kiyohide Fujimoto, Noriyoshi Miura, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
January 9, 2024
Novel image-guided marker aimed at organ-preserving therapies for prostate cancer
Koji Okihara, Takashi Ueda, Atsuko Fujihara, et al.
European Urology Oncology
|
December 8, 2023
A Fully Automated Artificial Intelligence System to Assist Pathologists' Diagnosis to Predict Histologically High-grade Urothelial Carcinoma from Digitized Urine Cytology Slides Using Deep Learning
Keisuke Tsuji, Masatomo Kaneko, Yuki Harada, et al.
Japanese Journal of Radiology
|
July 10, 2025
Longitudinal MRI changes after focal therapy for prostate cancer: cryotherapy vs. microwave tissue coagulation
Nana Kozawa, Kaori Yamada, Bunta Tokuda, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 101) with videos related to
Sort By:
Page
of 11
International Journal of Clinical Oncology
|
September 18, 2014
Initial experience of combined use of photodynamic diagnosis and narrow band imaging for detection of flat urothelial lesion
Yoshio Naya, Masakastu Oishi, Yasunori Yamada, et al.
World Journal of Urology
|
July 31, 2020
Moving away from systematic biopsies: image-guided prostate biopsy (in-bore biopsy, cognitive fusion biopsy, MRUS fusion biopsy) -literature review
Yasuhiro Yamada, Osamu Ukimura, Masatomo Kaneko, et al.
Biochemical and Biophysical Research Communications
|
February 26, 2017
CNPY2 promoted the proliferation of renal cell carcinoma cells and increased the expression of TP53
Hidefumi Taniguchi, Saya Ito, Takashi Ueda, et al.
Medicine
|
March 20, 2015
Importance of continuous sequential chemotherapy and multimodal treatment for advanced testicular cancer: a high-volume Japanese center experience
Terukazu Nakamura, Takashi Ueda, Masakatsu Oishi, et al.
Japanese Journal of Clinical Oncology
|
July 3, 2026
Screening for prognostic indicators in patients with metastatic castration-resistant prostate cancer after androgen receptor signaling inhibitor treatment for metastatic castration-sensitive prostate cancer
Keita Hayakawa, Takashi Ueda, Yusuke Gabata, et al.
International Immunopharmacology
|
September 12, 2022
Corrigendum to "A real-world study on the safety of the extended dosing schedule for nivolumab and pembrolizumab in patients with solid tumors" [Int. Immunopharmacol. 108 (2022) 108775]
Kenji Morimoto, Tadaaki Yamada, Yoshie Morimoto, et al.
Current Oncology (Toronto, Ont.)
|
November 26, 2025
A Multicenter Retrospective Study of Avelumab First-Line Maintenance and Subsequent Therapies for Locally Advanced and Metastatic Urothelial Carcinoma: Subgroup Analysis of First-Line Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin, and Gemcitabine Plus Cisplatin in the Japan AVElumab MAintenance and Continuous Treatment Study (JAVEMACS)
Masaomi Ikeda, Kiyohide Fujimoto, Noriyoshi Miura, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
January 9, 2024
Novel image-guided marker aimed at organ-preserving therapies for prostate cancer
Koji Okihara, Takashi Ueda, Atsuko Fujihara, et al.
European Urology Oncology
|
December 8, 2023
A Fully Automated Artificial Intelligence System to Assist Pathologists' Diagnosis to Predict Histologically High-grade Urothelial Carcinoma from Digitized Urine Cytology Slides Using Deep Learning
Keisuke Tsuji, Masatomo Kaneko, Yuki Harada, et al.
Japanese Journal of Radiology
|
July 10, 2025
Longitudinal MRI changes after focal therapy for prostate cancer: cryotherapy vs. microwave tissue coagulation
Nana Kozawa, Kaori Yamada, Bunta Tokuda, et al.
Page
of 11